Gillian Browne, PhD
Global Head of Commercial Enablement, Genome Engineering & Modulation
In this webinar, you will see:
The ability to perform large-scale, whole-genome screens has allowed for the rapid identification of gene pathways and targets relevant to health and disease. Several considerations need to be taken into account when designing your experiment:
- Knock-in, knockout, overexpression and knock-down
- Choosing between lentivirus and synthetic delivery methods
- Pooled vs. arrayed screens
In this webinar, we will discuss all these options to help you choose the right format and approach for your CRISPR screening applications.